🔗 Permalink

Inventor profile of:

Carsten Möller

City:

Berlin

Country:

Germany

Published Applications:

Last publication date:

2018-12-27

Top Assignees for applications by Carsten Möller

The entities that hold a legal rights for patent applications filed by inventor Möller Carsten:

Bayer Intellectual Property GmbH 9 Monheim, Germany
Bayer Pharma Aktiengesellschaft 8 Berlin, Germany
BAYER SCHERING PHARIMA AKTIENGESELL SCHAFT 1 Berlin, Germany
Bayer Intellectual Property 1 Monheim, Germany

Recent patent applications by Möller Carsten

Carsten Möller from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-12-27

US20180369257A1

Human necessities

Selective progesterone receptor modulators (SPRM) and stabilized estrogen level in patient

#2 | 2017-07-20

US20170202857A1

Human necessities

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases

#3 | 2015-12-03

US20150342962A1

Human necessities

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases

#4 | 2013-09-26

US20130252890A1

Chemistry; metallurgy

6,7-DIHYDRO-5H-BENZO[7]ANNULENE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS COMPRISING THEM, AND THE USE THEREOF FOR PRODUCTION OF MEDICAMENTS

#5 | 2013-03-21

US20130072464A1

Chemistry; metallurgy

Progesterone receptor antagonists

#6 | 2013-01-03

US20130005697A1

Chemistry; metallurgy

Progesterone receptor antagonists

#7 | 2012-12-13

US20120316145A1

Chemistry; metallurgy

17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzylidene derivatives, methods for the production thereof and use thereof for treating diseases

#8 | 2012-10-11

US20120258941A1

Chemistry; metallurgy

17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases

#9 | 2012-09-13

US20120232042A1

Chemistry; metallurgy

17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases

#10 | 2012-07-26

US20120190660A1

Chemistry; metallurgy

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-ethynylphenyl derivatives, methods for the production thereof and use thereof for treating diseases

#11 | 2012-07-19

US20120184515A1

Chemistry; metallurgy

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-methylene oxyalkylene aryl derivatives, process for preparation thereof, and use thereof for treatment of diseases

#12 | 2012-06-14

US20120149670A1

Human necessities

17-HYDROXY-17-PENTAFLUOROETHYL-ESTRA-4,9(10)-DIEN-11-ARYL DERIVATIVES, METHOD OF PRODUCTION THEREOF AND USE THEREOF FOR THE TREATMENT OF DISEASES

#13 | 2012-04-19

US20120094969A1

Human necessities

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases

#14 | 2011-05-12

US20110112057A1

Human necessities

Sequential administration of 20,20,21,21,21-pentafluoro-17-hydroxy-11Beta-[4-(hydroxyacetyl)phenyl]-19-nor-17Alpha-pregna-4,9-dien-3-one and one or more progestogens for the treatment of gynaecological disorders

#15 | 2009-09-24

US20090238836A1

Human necessities

Hip kinase for fertility control

InventorID:

13766 ⎘